Law360, New York (June 15, 2017, 8:29 PM EDT) -- Attorneys general throughout the U.S. have launched a joint investigation into how drugmakers might have contributed to the country’s opioid epidemic, the latest indication that pharmaceutical companies are being increasingly scrutinized as the crisis worsens.
The probe will focus on whether drugmakers’ marketing and sales tactics have prolonged an epidemic that the Centers for Disease Control and Prevention estimates killed more than 33,000 people in 2015. The bipartisan group, comprised of attorneys general from the majority of states, will use resources including subpoenas for documents and testimony during its investigation.
“I want to know whether drug companies, seeking higher profits, have...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!